We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Astrazeneca Plc | LSE:AZN | London | Ordinary Share | GB0009895292 | ORD SHS $0.25 |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
-23.00 | -0.23% | 9,946.00 | 9,944.00 | 9,946.00 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
9,974.00 | 9,867.00 | 9,867.00 | 836,346 | 08:29:28 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 45.81B | 5.96B | 3.8412 | 25.93 | 154.55B |
Date | Time | Source | Headline |
---|---|---|---|
20/11/2024 | 16:00 | UK RNS | AstraZeneca PLC Director/PDMR Shareholding |
19/11/2024 | 15:47 | ALNC | AstraZeneca "disappointed" as breast cancer drug blocked for NHS use |
18/11/2024 | 12:43 | ALNC | DIRECTOR DEALINGS: AstraZeneca chair and CAB Payments director buy |
18/11/2024 | 09:01 | ALNC | TOP NEWS: AstraZeneca hails recommended EU approval of Tagrisso |
18/11/2024 | 07:00 | UK RNS | AstraZeneca PLC Tagrisso recommended for EU approval - LAURA |
15/11/2024 | 14:00 | UK RNS | AstraZeneca PLC Director/PDMR Shareholding |
15/11/2024 | 11:04 | ALNC | DIRECTOR DEALINGS: AstraZeneca CEO Soriot buys GBP2 million in shares |
15/11/2024 | 10:00 | UK RNS | AstraZeneca PLC Director/PDMR Shareholding |
13/11/2024 | 16:00 | UK RNS | AstraZeneca PLC Director/PDMR Shareholding |
12/11/2024 | 19:50 | ALNC | IN BRIEF: Merck trial shows Koselugo effective in treating adults |
1 Year Astrazeneca Chart |
Intraday Astrazeneca Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions